We are live on ! Find out more
BCI

Bain Capital Investors Portfolio holdings

AUM $3.27B
1-Year Est. Return 3.23%
This Fund
S&P 500
This Quarter Est. Return
+31.96%
1 Year Est. Return
+3.23%
3 Year Est. Return
+87.05%
5 Year Est. Return
+97.69%
10 Year Est. Return
+813.76%
AUM
$3.82B
AUM Growth
-$886M
Cap. Flow
-$1.76B
Cap. Flow %
-46.02%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
NTNX icon
Nutanix
NTNX
+$926M

Top Sells

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$2.69B

Sector Composition

Rank Sector Weight
1 Healthcare 73.62%
2 Technology 26.12%
3 Communication Services 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGRY icon
1
Surgery Partners
SGRY
$2.01B
$1.61B 42.12%
49,946,972
– –
NTNX icon
2
Nutanix
NTNX
$17.4B
$999M 26.12%
+16,854,032
New +$926M
WAY
3
Waystar Holding Corp
WAY
$4.67B
$780M 20.41%
27,980,417
– –
AVAH icon
4
Aveanna Healthcare
AVAH
$1.98B
$424M 11.1%
81,600,880
– –
ADV icon
5
Advantage Solutions
ADV
$395M
$9.91M 0.26%
115,600
– –
CERE
6
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-65,679,781
Closed -$2.69B

Similar funds

AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return

Bain Capital Investors's Q3 2024 Portfolio in Review

As of Q3 2024, Bain Capital Investors held 6 positions worth $3.82B, down 19% from $4.71B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bain Capital Investors withdrew a net $1.76B in Q3 2024, closing 1 position. Its most notable exit was Cerevel Therapeutics Holdings, Inc. Common Stock, an estimated $2.69B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 100% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Bain Capital Investors opened a new position in Nutanix worth $999M.

  • Bain Capital Investors's largest Q3 2024 buy was Nutanix: 16,854,032 shares worth $999M.
  • Bain Capital Investors fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $2.69B.
  • Bain Capital Investors's ten largest holdings make up 100% of its $3.82B portfolio in Q3 2024.
  • Bain Capital Investors opened 1 new position and closed 1 in Q3 2024.
  • Bain Capital Investors's portfolio value fell 19% quarter-over-quarter to $3.82B.

Based on Bain Capital Investors's 13F filing for Q3 2024, filed 14 Nov 2024.